Found: 12
Select item for more details and to access through your institution.
Inflammatory Markers in the Second Trimester Prior to Clinical Onset of Preeclampsia, Intrauterine Growth Restriction, and Spontaneous Preterm Birth.
- Published in:
- Inflammation, 2013, v. 36, n. 4, p. 907, doi. 10.1007/s10753-013-9619-x
- By:
- Publication type:
- Article
The glucagon receptor antagonist LY2409021 does not affect gastrointestinal-mediated glucose disposal or the incretin effect in individuals with and without type 2 diabetes.
- Published in:
- European Journal of Endocrinology, 2022, v. 187, n. 4, p. 507, doi. 10.1530/EJE-22-0291
- By:
- Publication type:
- Article
The glucagon receptor antagonist LY2409021 has no effect on postprandial glucose in type 2 diabetes.
- Published in:
- European Journal of Endocrinology, 2022, v. 186, n. 2, p. 207, doi. 10.1530/EJE-21-0865
- By:
- Publication type:
- Article
Clinical effects of SGLT2 inhibitors in seven persons with HNF1A‐MODY (MODY3).
- Published in:
- Diabetic Medicine, 2024, v. 41, n. 10, p. 1, doi. 10.1111/dme.15387
- By:
- Publication type:
- Article
The Role of Glucagon in the Acute Therapeutic Effects of SGLT2 Inhibition.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Efficacy and Safety of Glimepiride With or Without Linagliptin Treatment in Patients With HNF1A Diabetes (Maturity-Onset Diabetes of the Young Type 3): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial (GLIMLINA).
- Published in:
- 2020
- By:
- Publication type:
- journal article
323-OR: SGLT2 Inhibition Promotes Myocardial Ketone Utilization in the Normal and Failing Heart.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-323-OR
- By:
- Publication type:
- Article
The Role of Glucagon in the Acute Therapeutic Effects of SGLT2 Inhibition.
- Published in:
- Diabetes, 2020, v. 69, n. 12, p. 2619, doi. 10.2337/db20-0369
- By:
- Publication type:
- Article
GIP and GLP-1 Potentiate Sulfonylurea-Induced Insulin Secretion in Hepatocyte Nuclear Factor 1α Mutation Carriers.
- Published in:
- 2020
- By:
- Publication type:
- journal article
923-P: Improved Glycemic Variability and Control without Increased Risk of Hypoglycemia when Linagliptin Is Added to Glimepiride Therapy in Patients with HNF1A-Diabetes.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-923-P
- By:
- Publication type:
- Article
981-P: GIP and GLP-1 Potentiate Sulfonylurea-Induced Insulin Secretion in HNF1A Diabetes.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-981-P
- By:
- Publication type:
- Article
1952-P: Glucagon Receptor Antagonism Increases Plasma Amino Acids and Glucagon.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1952-P
- By:
- Publication type:
- Article